UBS OCONNOR LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 167 filers reported holding CARDLYTICS INC in Q4 2021. The put-call ratio across all filers is 3.11 and the average weighting 0.6%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2021$5,456,000,000
-38.6%
65,000
-7.1%
0.04%
-45.6%
Q2 2021$8,885,000,000
+15.7%
70,0000.0%0.08%
-28.8%
Q1 2021$7,679,000,000
+262.7%
70,000
+133.3%
0.11%
+105.6%
Q3 2020$2,117,000,000
+236.6%
30,000
+200.0%
0.05%
+200.0%
Q4 2019$629,000,000
-89.6%
10,000
-94.4%
0.02%
-89.3%
Q3 2019$6,034,000,000
-32.6%
180,000
-47.7%
0.17%
-2.9%
Q2 2019$8,946,000,000
+450.9%
344,354
+129.6%
0.17%
+193.2%
Q4 2018$1,624,000,000150,0000.06%
Other shareholders
CARDLYTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
CAS Investment Partners, LLC 4,488,972$640,891,00035.51%
Antipodean Advisors LLC 656,000$93,657,00026.30%
KPS Global Asset Management UK Ltd 1,021,830$145,887,00021.39%
BRIGHTLIGHT CAPITAL MANAGEMENT LP 302,700$43,216,00017.58%
Oakcliff Capital Partners, LP 269,895$38,533,00015.30%
Alua Capital Management LP 920,259$131,385,0009.19%
Covey Capital Advisors, LLC 47,736$6,815,0005.95%
EVR Research LP 50,000$7,139,0005.83%
683 Capital Management, LLC 659,997$94,228,0004.46%
Hidden Lake Asset Management LP 72,900$10,408,0004.08%
View complete list of CARDLYTICS INC shareholders